CCAA and Chapter 11 courts back incentive plans for drug company management

Courts in Canada and the US have approved incentive plans for the senior management of Canadian pharmaceutical company Aralez, designed to reduce debtor-in-possession funding for its Chapter 11 and Companies Creditor Arrangement Act proceedings.

Get unlimited access to all Global Restructuring Review content